Table I.
Association of DNM1L expression with clinicopathological factors.
DNM1L expression | |||||
---|---|---|---|---|---|
Clinicopathological parameters | No. | Negative | Positive | Chi-square | P-value |
Age (years) | |||||
<60 | 63 | 12 | 51 | 1.154 | 0.283 |
≥60 | 87 | 11 | 76 | ||
Sex | |||||
Male | 105 | 17 | 88 | 0.198 | 0.656 |
Female | 45 | 6 | 39 | ||
Tumor diameter (cm) | |||||
<5.0 | 99 | 17 | 82 | 0.758 | 0.384 |
≥5.0 | 51 | 6 | 45 | ||
Tumor grade | |||||
Well | 25 | 6 | 19 | 2.284 | 0.319 |
Moderately | 70 | 11 | 59 | ||
Poorly | 55 | 6 | 49 | ||
Depth of invasion | |||||
T1+T2 | 56 | 13 | 43 | 4.257 | 0.039 |
T3+T4 | 94 | 10 | 84 | ||
TNM-stage | |||||
I+II | 70 | 16 | 54 | 5.723 | 0.017 |
III+IV | 80 | 7 | 73 | ||
Lymph node metastasis | |||||
Negative | 60 | 16 | 44 | 9.894 | 0.002 |
Positive | 90 | 7 | 83 |
TNM, tumor node metastatis; DNM1L, dynamin-1-like protein.